What is the price target for MSDL stock?
13 analysts have analysed MSDL and the average price target is 16.19 USD. This implies a price increase of 15.99% is expected in the next year compared to the current price of 13.96.
NYSE:MSDL • US61774A1034
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for MORGAN STANLEY DIRECT LENDIN (MSDL).
| Date | Firm | Action | From → To |
|---|---|---|---|
| 2026-03-13 | UBS | Maintains | Neutral -> Neutral |
| 2026-03-13 | JP Morgan | Maintains | Neutral -> Neutral |
| 2026-03-05 | RBC Capital | Maintains | Sector Perform -> Sector Perform |
| 2026-03-02 | Keefe, Bruyette & Woods | Maintains | Market Perform -> Market Perform |
| 2026-03-02 | Wells Fargo | Maintains | Equal-Weight -> Equal-Weight |
| 2026-01-07 | Wells Fargo | Downgrade | Overweight -> Equal-Weight |
| 2025-11-26 | RBC Capital | Downgrade | Outperform -> Sector Perform |
| 2025-11-10 | Keefe, Bruyette & Woods | Maintains | Market Perform -> Market Perform |
| 2025-11-10 | JP Morgan | Maintains | Neutral -> Neutral |
| 2025-10-14 | UBS | Maintains | Neutral -> Neutral |
| 2025-10-10 | LUCID CAPITAL MARKETS | Initiate | Buy |
| 2025-10-06 | Wells Fargo | Upgrade | Equal-Weight -> Overweight |
| 2025-10-01 | JP Morgan | Maintains | Neutral -> Neutral |
| 2025-09-10 | RBC Capital | Maintains | Outperform -> Outperform |
| 2025-08-14 | Wells Fargo | Maintains | Equal-Weight -> Equal-Weight |
| 2025-07-16 | UBS | Maintains | Neutral -> Neutral |
| 2025-05-22 | RBC Capital | Maintains | Outperform -> Outperform |
| 2025-04-28 | Wells Fargo | Maintains | Equal-Weight -> Equal-Weight |
| 2025-04-24 | JP Morgan | Maintains | Neutral -> Neutral |
| 2025-04-17 | UBS | Maintains | Neutral -> Neutral |
| 2025-04-08 | Keefe, Bruyette & Woods | Maintains | Market Perform -> Market Perform |
| 2025-03-04 | RBC Capital | Reiterate | Outperform -> Outperform |
| 2025-03-03 | Wells Fargo | Maintains | Equal-Weight -> Equal-Weight |
| 2025-01-29 | Wells Fargo | Maintains | Equal-Weight -> Equal-Weight |
| 2024-09-13 | RBC Capital | Reiterate | Outperform -> Outperform |
| 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | ||
|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 367.738M 59.47% | 416.075M 13.14% | 397.287M -4.52% | 368.07M -7.35% | 326.48M -11.30% | 298.98M -8.42% | |
| EBITDA YoY % growth | N/A | N/A | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | 199.58M 55.50% | 222.672M 11.57% | 178.84M -19.68% | 208.08M 16.35% | N/A | N/A | |
| Operating Margin | 54.27% | 53.52% | 45.02% | 56.53% | N/A | N/A | |
| EPS YoY % growth | N/A | 2.49 -8.30% | 2.14 -14.06% | 1.87 -12.57% | 1.82 -2.74% | N/A |
All data in USD
| Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | Q1 / 27 | Q2 / 27 | Q3 / 27 | Q4 / 27 | Q1 / 28 | Q2 / 28 | Q3 / 28 | Q4 / 28 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | 0.47 -9.21% | 0.47 -5.58% | 0.46 -7.32% | 0.46 -25.50% | 0.46 -3.50% | 0.46 -3.50% | 0.46 -0.58% | 0.46 0.10% | 0.45 -0.37% | 0.45 -0.37% | 0.45 -1.48% | 0.45 -1.84% |
| Revenue Q2Q % growth | 94.679M -6.68% | 93.465M 1.84% | 91.658M -8.09% | 90.861M -12.91% | 89.077M -5.92% | 89.554M -4.18% | 90.174M -1.62% | 90.413M -0.49% | 74.654M -16.19% | 74.695M -16.59% | 74.777M -17.07% | 74.853M -17.21% |
| EBITDA Q2Q % growth | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
All data in USD
13 analysts have analysed MSDL and the average price target is 16.19 USD. This implies a price increase of 15.99% is expected in the next year compared to the current price of 13.96.
MORGAN STANLEY DIRECT LENDIN (MSDL) will report earnings on 2026-05-06.
The consensus EPS estimate for the next earnings of MORGAN STANLEY DIRECT LENDIN (MSDL) is 0.47 USD and the consensus revenue estimate is 94.68M USD.
The expected long term growth rate for MORGAN STANLEY DIRECT LENDIN (MSDL) is -9.67%.